Urinary hyaluronidase activity is closely related to vasopressinergic system following an oral water load in men: a potential role in blood pressure regulation and early stages of hypertension development.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2024
Historique:
received: 28 11 2023
accepted: 29 05 2024
medline: 10 7 2024
pubmed: 10 7 2024
entrez: 10 7 2024
Statut: epublish

Résumé

Blood pressure (BP) regulation is a complex process involving several factors, among which water-sodium balance holds a prominent place. Arginin-vasopressin (AVP), a key player in water metabolism, has been evoked in hypertension development since the 1980s, but, to date, the matter is still controversial. Hyaluronic acid metabolism has been reported to be involved in renal water management, and AVP appears to increase hyaluronidase activity resulting in decreased high-molecular-weight hyaluronan content in the renal interstitium, facilitating water reabsorption in collecting ducts. Hence, our aim was to evaluate urinary hyaluronidase activity in response to an oral water load in hypertensive patients (HT, n=21) compared to normotensive subjects with (NT+, n=36) and without (NT-, n=29) a family history of hypertension, and to study its association with BP and AVP system activation, expressed by serum copeptin levels and urine Aquaporin 2 (AQP2)/creatinine ratio. Eighty-six Caucasian men were studied. Water load test consisted in oral administration of 15-20 ml of water/kg body weight over 40-45 min. BP, heart rate, serum copeptin, urine hyaluronidase activity and AQP2 were monitored for 4 hours. In response to water drinking, BP raised in all groups with a peak at 20-40 min. Baseline levels of serum copeptin, urinary hyaluronidase activity and AQP2/creatinine ratio were similar among groups and all decreased after water load, reaching their nadir at 120 min and then gradually recovering to baseline values. Significantly, a blunted reduction in serum copeptin, urinary hyaluronidase activity and AQP2/creatinine ratio was observed in NT+ compared to NT- subjects. A strong positive correlation was also found between urinary hyaluronidase activity and AQP2/creatinine ratio, and, although limited to the NT- group, both parameters were positively associated with systolic BP. Our results demonstrate for the first time the existence in men of a close association between urinary hyaluronidase activity and vasopressinergic system and suggest that NT+ subjects have a reduced ability to respond to water loading possibly contributing to the blood volume expansion involved in early-stage hypertension. Considering these data, AVP could play a central role in BP regulation by affecting water metabolism through both hyaluronidase activity and AQP2 channel expression.

Identifiants

pubmed: 38982989
doi: 10.3389/fendo.2024.1346082
pmc: PMC11231081
doi:

Substances chimiques

Hyaluronoglucosaminidase EC 3.2.1.35
Aquaporin 2 0
Arginine Vasopressin 113-79-1
AQP2 protein, human 0
copeptins 0
Vasopressins 11000-17-2
Glycopeptides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1346082

Informations de copyright

Copyright © 2024 Calvi, Bongrani, Verzicco, Figus, Vicini, Coghi, Montanari and Cabassi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Anna Calvi (A)

Clinica e Terapia Medica, Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy.

Alice Bongrani (A)

Cardiorenal and Hypertension Research Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.

Ignazio Verzicco (I)

Clinica e Terapia Medica, Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy.

Giuliano Figus (G)

Clinica e Terapia Medica, Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy.

Vanni Vicini (V)

Clinica e Terapia Medica, Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy.

Pietro Coghi (P)

Clinica e Terapia Medica, Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy.

Alberto Montanari (A)

Cardiorenal and Hypertension Research Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.

Aderville Cabassi (A)

Clinica e Terapia Medica, Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy.
Cardiorenal and Hypertension Research Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH